Diplomat Specialty Pharmacy® and Diplomat Specialty Infusion Group® are joining the Optum® family.

To learn more about what this means for you, visit our FAQ pages:

Specialty Pharmacy FAQ  •  Infusion Pharmacy FAQ

FABRAZYME®

Fabrazyme (agalsidase beta)

FDA INDICATION: Fabry disease. Package Insert

DISTRIBUTOR: Sanofi Genzyme

ROUTE OF ADMINISTRATION: Intravenous

FORM: Lyophilized

DOSAGE AND ADMINISTRATION: 1 mg/kg body weight infused every two weeks.

HOW SUPPLIED: 35 mg vials supplied in single-use, clear glass 20 mL vials. 5 mg vials supplied in single-use, clear 5 mL vials.

DILUENT: 0.9% sodium chloride injection

MAX INFUSION RATE: 0.25 mg/min

STORAGE REQUIREMENTS: Refrigerate vials at 2–8°C (36–46°F).

OTHER WEBSITES: fabrazyme.comFabryCommunity.comCareConnectPSS.com